SHILPA MEDICARE
|
The Current P/E Ratio of SHILPA MEDICARE is 71.42.
Share Price | ₹671.8 | Apr 17,2025 |
Market Cap | ₹6,570.2 Cr | |
Earnings-TTM | ₹92.0 Cr | TTM-Consolidated Results |
Price/Earnings | 71.42x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SHILPA MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹6,570.2 Cr] as on Apr 17,2025
(/) Earnings [ ₹92.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 71.42x ]
Thus, for SHILPA MEDICARE , the investors are currently willing to pay 71.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHILPA MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHILPA MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SHILPA MEDICARE
PE Ratio Performance Analysis for SHILPA MEDICARE
- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 42.73x.
- SHILPA MEDICARE 's operated at median p/e ratio of 18.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 125.64x.
- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SHILPA MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SHILPA MEDICARE | 92.00 | 71.42 | 6,570.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.58 | 420,136.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 72.41 | 149,680.0 |
CIPLA LTD | 5,000.43 | 24.48 | 122,394.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.16 | 110,159.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.89 | 97,105.6 |
MANKIND PHARMA LTD | 2,050.73 | 51.96 | 106,555.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 18.22 | 83,658.3 |
LUPIN LTD | 2,892.10 | 30.57 | 88,425.2 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.45 | 68,067.0 |
ABBOTT INDIA LTD | 1,334.46 | 48.86 | 65,197.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHILPA MEDICARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.89x |
Max industry PE | 72.41x |
Median industry PE | 36.58x |
Average industry PE | 41.00x |
You may also like the below Video Courses